A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

Part of paid clinical trials in Duarte, California.

Sponsor
AstraZeneca
Study ID
NCT07681596
Phase
PHASE1/PHASE2
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • AZD4045 — BIOLOGICAL
    Allogeneic Chimeric Antigen Receptor T cell (CAR-T) Therapy Targeting B Cell Maturation Antigen (BCMA)
  • Daratumumab — DRUG
    Anti-CD38 monoclonal antibody
  • Aldesleukin — DRUG
    Recombinant human IL-2

Study Details

The purpose of this study is to assess the safety, tolerability, preliminary efficacy, cellular kinetics, and other exploratory endpoints of AZD4045 as a monotherapy and in association with daratumumab and aldesleukin for the treatment of adult participants with RRMM.

Key Dates

Start date
Jul 9, 2026
Status verified
Jun 2026
Primary completion
Oct 30, 2029
Completion
Oct 30, 2029

Study Design

Enrollment
101 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Module 1: AZD4045 monotherapy
  • Experimental: Module 1: AZD4045 in association with daratumumab and aldesleukin

Primary Outcome Measure

Adverse events (AEs) and serious AEs (SAEs) [ Time Frame: Through study completion, an average of 2 years ]

Central Contacts

Locations (10)

FacilityCityStateZIPSite coordinators
Research SiteDuarteCalifornia91010-
Research SiteDenverColorado80218-
Research SiteTampaFlorida33612-
Research SiteAtlantaGeorgia30322-
Research SiteSt LouisMissouri63110-
Research SiteHackensackNew Jersey07601-
Research SiteClevelandOhio44195-
Research SiteNashvilleTennessee37203-
Research SiteHoustonTexas77030-
Research SiteMilwaukeeWisconsin53226-

Find similar trials in Duarte, CA

Related Studies